Viewing Study NCT02153320


Ignite Creation Date: 2025-12-25 @ 4:06 AM
Ignite Modification Date: 2026-03-04 @ 12:44 AM
Study NCT ID: NCT02153320
Status: COMPLETED
Last Update Posted: 2017-05-30
First Post: 2014-05-22
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Study to Evaluate the Persistence of the Cellular and Humoral Immune Response Following Vaccinations With GlaxoSmithKline (GSK) Biologicals' Candidate Vaccines Containing HBsAg and Different Adjuvants in Healthy Adult Volunteers
Sponsor: GlaxoSmithKline
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2005-09-05
Start Date Type: ACTUAL
Primary Completion Date: 2005-10-28
Primary Completion Date Type: ACTUAL
Completion Date: 2005-10-28
Completion Date Type: ACTUAL
First Submit Date: 2014-05-22
First Submit QC Date: None
Study First Post Date: 2014-06-03
Study First Post Date Type: ESTIMATED
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: None
Results First Post Date Type: None
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2017-05-24
Last Update Post Date: 2017-05-30
Last Update Post Date Type: ACTUAL